Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma

Summary

The purpose of this study is to evaluate the safety and tolerability of the dry powder formulation of ASM-024 following single and multiple administration by inhalation of ascending doses in healthy subjects and subjects with stable moderate asthma.

Timeline

Start

2013-03

Primary completion

2014-03

Completion

2014-12

Outcome

Outcome not reported

Stopped: “Lack of efficacy”

Drugs

Indications